For Confidential Help, Call
(866) 729-1012

Cannabis Use & Related Disorders in Youth During the Age of Legalization

A Part of SunCloud's Continuing Education Series of Events

The Role of Safety Behaviors in Maintaining Mental Health Conditions
Presented by: Christopher Hammond, MD
June 21st, 2024

Topics Covered: 

  • Identify important issues related to adolescent and young adult cannabis use and cannabis-related disorders during this era of changing cannabis legalization
  • Describe the effects of early adolescent exposure to cannabis and cannabinoids, including Δ9-THC and CBD, on neurodevelopment, psychosocial, and health outcomes
  • Discuss assessment, diagnosis, and treatment of cannabis use disorders in youth
  • Formulate evidence-informed treatment plans for youth cannabis use disorders that incorporate evidence-based psychosocial interventions and, when appropriate, adjunctive medication treatment strategies to improve outcomes.

Watch the Presentation

About the Speaker

Presented by: Christopher Hammond, MD, PhD | Triple Board-Certified General Psychiatrist, Child & Adolescent Psychiatrist, & Addiction Medicine Physician

Dr. Christopher Hammond is a triple board-certified general psychiatrist, child & adolescent psychiatrist, and addiction medicine physician, and an Associate Professor of Psychiatry & Behavioral Sciences in the Division of Child & Adolescent Psychiatry at Johns Hopkins University School of Medicine (SOM) with secondary appointments in the Behavioral Pharmacology Research Unit (Substance Abuse Services), Department of Pediatrics, and Division of Adolescent/Young Adult Medicine.  He has over 10 years of clinical and research experience working with children and families affected by substance use and addictive disorders and has published extensively on clinical best practices in this area.  Dr. Hammond serves as Director of the Co-occurring Disorders in Adolescents & Young Adults (CODA) Clinical and Research Programs at Johns Hopkins University SOM.

 

Joint Accreditation Statement

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Galen Mental Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

 

Stay Connected With UsBlog & News

Accreditations, Certifications & Licensing

LegitScript approved
DASA License. Department of Alcohol and Substance Abuse.
Joint Commission Behavioral Health Care Accreditation.
EDC Member
IAEDP Member

The Joint Commission signifies that all people always experience the safest, highest quality, best-value health care across all settings with a devotion to patient safety. The Gold Seal, is a symbol to the community and patients we serve that SunCloud Health has placed an emphasis on quality of care.

We are here for you.

One of the nations most trusted names in treating substance use addictions, eating disorders, mood disorders, PTSD and related traumas.
(866) 729-1012